Omeros Tax Provision vs Research Development Analysis

OMER Stock

USD 3.73 0.01 0.27%

Omeros financial indicator trend analysis is much more than just breaking down Omeros prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Omeros is a good investment. Please check the relationship between Omeros Tax Provision and its Research Development accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omeros. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.

Tax Provision vs Research Development

Tax Provision vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Omeros Tax Provision account and Research Development. At this time, the significance of the direction appears to have strong relationship.

The correlation between Omeros' Tax Provision and Research Development is 0.69. Overlapping area represents the amount of variation of Tax Provision that can explain the historical movement of Research Development in the same time period over historical financial statements of Omeros, assuming nothing else is changed. The correlation between historical values of Omeros' Tax Provision and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Tax Provision of Omeros are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Tax Provision i.e., Omeros' Tax Provision and Research Development go up and down completely randomly.

Correlation Coefficient

0.69

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Research Development

Most indicators from Omeros' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Omeros current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omeros. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.Omeros reported last year Tax Provision of (4.16 Million). As of 05/04/2024, Discontinued Operations is likely to grow to about 283.6 M, while Selling General Administrative is likely to drop slightly above 34.9 M.

	2021	2022	2023	2024 (projected)
Interest Expense	19.7M	22.7M	30.8M	32.4M
Depreciation And Amortization	1.7M	4.1M	920K	873.8K

Interest Expense Depreciation And Amortization

Omeros fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Common Stock Shares Outstanding		0.75	0.66	0.86	0.72	-0.08	0.76	-0.59	0.63	-0.48	0.72	0.43	0.65	0.41	0.62	0.78	0.58	0.99	0.69	0.59	0.82	0.46	0.65	0.74	0.76	0.4
Total Assets	0.75		0.92	0.61	0.85	0.06	0.75	-0.4	0.9	-0.52	0.6	0.48	0.94	0.77	0.93	0.95	0.82	0.69	0.86	0.85	0.69	0.74	0.91	0.78	0.98	0.7
Short Long Term Debt Total	0.66	0.92		0.5	0.64	0.32	0.59	-0.38	0.99	-0.35	0.65	0.5	0.96	0.81	0.96	0.89	0.63	0.63	0.78	0.75	0.62	0.83	0.78	0.66	0.84	0.49
Other Current Liab	0.86	0.61	0.5		0.68	-0.21	0.83	-0.52	0.48	-0.35	0.6	0.34	0.52	0.28	0.45	0.65	0.48	0.84	0.57	0.5	0.8	0.16	0.56	0.81	0.63	0.27
Total Current Liabilities	0.72	0.85	0.64	0.68		0.03	0.65	-0.33	0.65	-0.35	0.41	0.23	0.65	0.58	0.61	0.73	0.95	0.66	0.71	0.6	0.52	0.44	0.71	0.62	0.91	0.89
Total Stockholder Equity	-0.08	0.06	0.32	-0.21	0.03		-0.47	0.07	0.33	0.68	0.18	0.08	0.08	0.15	0.12	-0.05	0.16	-0.13	-0.08	-0.32	-0.23	0.29	-0.27	-0.43	0.05	0.13
Property Plant And Equipment Net	0.76	0.75	0.59	0.83	0.65	-0.47		-0.44	0.54	-0.67	0.55	0.5	0.72	0.42	0.67	0.79	0.49	0.73	0.66	0.79	0.81	0.29	0.81	0.99	0.72	0.32
Current Deferred Revenue	-0.59	-0.4	-0.38	-0.52	-0.33	0.07	-0.44		-0.38	0.27	-0.47	-0.18	-0.36	-0.26	-0.34	-0.43	-0.27	-0.56	-0.41	-0.38	-0.53	-0.25	-0.39	-0.44	-0.4	-0.14
Net Debt	0.63	0.9	0.99	0.48	0.65	0.33	0.54	-0.38		-0.33	0.56	0.35	0.93	0.88	0.94	0.88	0.62	0.61	0.83	0.72	0.61	0.82	0.76	0.63	0.84	0.52
Retained Earnings	-0.48	-0.52	-0.35	-0.35	-0.35	0.68	-0.67	0.27	-0.33		-0.28	-0.24	-0.54	-0.4	-0.52	-0.57	-0.27	-0.51	-0.53	-0.73	-0.49	-0.49	-0.7	-0.68	-0.48	-0.22
Accounts Payable	0.72	0.6	0.65	0.6	0.41	0.18	0.55	-0.47	0.56	-0.28		0.79	0.65	0.19	0.62	0.57	0.38	0.66	0.31	0.45	0.58	0.53	0.47	0.54	0.53	0.1
Cash	0.43	0.48	0.5	0.34	0.23	0.08	0.5	-0.18	0.35	-0.24	0.79		0.56	-0.05	0.54	0.43	0.29	0.35	0.07	0.43	0.36	0.39	0.42	0.46	0.4	0.01
Non Current Assets Total	0.65	0.94	0.96	0.52	0.65	0.08	0.72	-0.36	0.93	-0.54	0.65	0.56		0.79	0.99	0.91	0.62	0.62	0.77	0.86	0.64	0.79	0.88	0.79	0.85	0.48
Non Currrent Assets Other	0.41	0.77	0.81	0.28	0.58	0.15	0.42	-0.26	0.88	-0.4	0.19	-0.05	0.79		0.81	0.76	0.53	0.42	0.86	0.69	0.45	0.72	0.72	0.53	0.72	0.58
Other Assets	0.62	0.93	0.96	0.45	0.61	0.12	0.67	-0.34	0.94	-0.52	0.62	0.54	0.99	0.81		0.9	0.59	0.59	0.78	0.85	0.62	0.82	0.86	0.74	0.84	0.47
Cash And Short Term Investments	0.78	0.95	0.89	0.65	0.73	-0.05	0.79	-0.43	0.88	-0.57	0.57	0.43	0.91	0.76	0.9		0.65	0.75	0.93	0.86	0.84	0.68	0.9	0.83	0.93	0.54
Net Receivables	0.58	0.82	0.63	0.48	0.95	0.16	0.49	-0.27	0.62	-0.27	0.38	0.29	0.62	0.53	0.59	0.65		0.5	0.6	0.56	0.33	0.52	0.67	0.46	0.89	0.94
Common Stock Total Equity	0.99	0.69	0.63	0.84	0.66	-0.13	0.73	-0.56	0.61	-0.51	0.66	0.35	0.62	0.42	0.59	0.75	0.5		0.68	0.58	0.81	0.46	0.62	0.73	0.7	0.34
Short Term Investments	0.69	0.86	0.78	0.57	0.71	-0.08	0.66	-0.41	0.83	-0.53	0.31	0.07	0.77	0.86	0.78	0.93	0.6	0.68		0.78	0.79	0.59	0.82	0.73	0.86	0.59
Non Current Liabilities Total	0.59	0.85	0.75	0.5	0.6	-0.32	0.79	-0.38	0.72	-0.73	0.45	0.43	0.86	0.69	0.85	0.86	0.56	0.58	0.78		0.64	0.62	0.99	0.83	0.8	0.48
Other Current Assets	0.82	0.69	0.62	0.8	0.52	-0.23	0.81	-0.53	0.61	-0.49	0.58	0.36	0.64	0.45	0.62	0.84	0.33	0.81	0.79	0.64		0.33	0.66	0.83	0.68	0.17
Other Stockholder Equity	0.46	0.74	0.83	0.16	0.44	0.29	0.29	-0.25	0.82	-0.49	0.53	0.39	0.79	0.72	0.82	0.68	0.52	0.46	0.59	0.62	0.33		0.64	0.36	0.66	0.43
Total Liab	0.65	0.91	0.78	0.56	0.71	-0.27	0.81	-0.39	0.76	-0.7	0.47	0.42	0.88	0.72	0.86	0.9	0.67	0.62	0.82	0.99	0.66	0.64		0.85	0.87	0.58
Property Plant And Equipment Gross	0.74	0.78	0.66	0.81	0.62	-0.43	0.99	-0.44	0.63	-0.68	0.54	0.46	0.79	0.53	0.74	0.83	0.46	0.73	0.73	0.83	0.83	0.36	0.85		0.73	0.31
Total Current Assets	0.76	0.98	0.84	0.63	0.91	0.05	0.72	-0.4	0.84	-0.48	0.53	0.4	0.85	0.72	0.84	0.93	0.89	0.7	0.86	0.8	0.68	0.66	0.87	0.73		0.79
Short Term Debt	0.4	0.7	0.49	0.27	0.89	0.13	0.32	-0.14	0.52	-0.22	0.1	0.01	0.48	0.58	0.47	0.54	0.94	0.34	0.59	0.48	0.17	0.43	0.58	0.31	0.79

Click cells to compare fundamentals

Omeros Account Relationship Matchups

Omeros fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	49.5M	57.2M	62.3M	62.7M	62.7M	38.8M
Total Assets	137.0M	181.0M	419.3M	591.0M	378.3M	397.2M
Short Long Term Debt Total	35.8M	32.6M	347.8M	342.0M	361.6M	379.7M
Other Current Liab	46.6M	28.8M	33.1M	32.0M	31.9M	18.5M
Total Current Liabilities	55.5M	36.7M	51.8M	136.7M	53.3M	35.4M
Total Stockholder Equity	(734.6M)	(872.7M)	23.8M	85.7M	(25.0M)	(26.2M)
Property Plant And Equipment Net	30.9M	28.1M	30.0M	23.3M	20.6M	21.6M
Net Debt	32.7M	22.1M	247.0M	331.0M	354.5M	372.2M
Retained Earnings	(734.6M)	(872.7M)	(683.1M)	(635.7M)	(753.5M)	(715.9M)
Accounts Payable	5.3M	4.2M	13.4M	6.0M	7.7M	5.1M
Cash	3.1M	10.5M	100.8M	11.0M	7.1M	11.3M
Non Current Assets Total	33.2M	29.8M	171.4M	147.7M	160.4M	168.4M
Non Currrent Assets Other	1.2M	625K	67K	124.5M	139.8M	146.8M
Other Assets	2.3M	27.2M	141.4M	124.5M	143.2M	150.3M
Cash And Short Term Investments	60.8M	135.0M	157.3M	194.9M	171.8M	180.4M
Net Receivables	35.2M	3.8M	82.5M	242.0M	37.5M	30.1M
Common Stock Total Equity	542K	616K	626K	628K	722.2K	404.0K
Short Term Investments	57.7M	124.5M	56.5M	183.9M	164.7M	173.0M
Liabilities And Stockholders Equity	(488.6M)	(570.9M)	419.3M	591.0M	378.3M	397.2M
Non Current Liabilities Total	190.5M	265.1M	343.7M	368.6M	349.9M	367.4M
Other Current Assets	6.6M	11.1M	8.1M	6.3M	8.6M	9.0M
Other Stockholder Equity	(542K)	(616K)	706.3M	720.8M	727.9M	764.3M
Total Liab	246.0M	301.8M	395.5M	505.3M	403.3M	423.4M
Property Plant And Equipment Gross	30.9M	28.1M	30.0M	23.3M	26.7M	28.1M
Total Current Assets	103.7M	151.3M	247.9M	443.2M	217.9M	228.8M
Short Term Debt	3.5M	3.8M	5.3M	98.7M	13.7M	11.5M
Common Stock	542K	616K	626K	721.4M	611K	580.5K
Property Plant Equipment	3.8M	28.1M	30.0M	23.3M	26.7M	28.1M
Long Term Debt	158.2M	236.3M	313.5M	220.9M	254.0M	266.7M
Net Tangible Assets	(76.7M)	(92.0M)	52.9M	233.2M	268.2M	281.6M
Retained Earnings Total Equity	(734.6M)	(872.7M)	(683.1M)	(635.7M)	(572.1M)	(600.8M)
Long Term Debt Total	158.2M	236.3M	313.5M	220.9M	254.0M	159.7M
Capital Surpluse	625.0M	751.3M	706.3M	720.8M	828.9M	593.0M
Other Liab	8.7M	8.2M	1.1M	444K	399.6K	379.6K
Capital Lease Obligations	35.8M	32.6M	34.4M	26.7M	30.7M	20.9M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Omeros in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Omeros' short interest history, or implied volatility extrapolated from Omeros options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Omeros is a strong investment it is important to analyze Omeros' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omeros' future performance. For an informed investment choice regarding Omeros Stock, refer to the following important reports:

How To Invest In Omeros

Details

Is Omeros Stock a good investment?

Details

What is Omeros' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omeros. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.

Note that the Omeros information on this page should be used as a complementary analysis to other Omeros' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Omeros Stock analysis

When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.

	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope

Is Omeros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omeros. If investors know Omeros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omeros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.79)

Revenue Per Share

(0.48)

Quarterly Revenue Growth

0.149

Return On Assets

(0.21)

Return On Equity

(5.76)

The market value of Omeros is measured differently than its book value, which is the value of Omeros that is recorded on the company's balance sheet. Investors also form their own opinion of Omeros' value that differs from its market value or its book value, called intrinsic value, which is Omeros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omeros' market value can be influenced by many factors that don't directly affect Omeros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Omeros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omeros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omeros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Omeros Tax Provision vs Research Development Analysis

Tax Provision vs Research Development

Tax Provision vs Research Development Correlation Analysis

Correlation Coefficient

Tax Provision

Research Development

Omeros fundamental ratios Correlations

Omeros Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Omeros fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Omeros Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding
Net Debt	+ 0.99	Short Long Term Debt Total
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Other Assets	+ 0.99	Non Current Assets Total
Total Liab	+ 0.99	Non Current Liabilities Total
Total Current Assets	+ 0.98	Total Assets

Non Current Liabilities Total	- 0.73	Retained Earnings
Total Liab	- 0.7	Retained Earnings
Property Plant And Equipment Gross	- 0.68	Retained Earnings
Retained Earnings	- 0.67	Property Plant And Equipment Net
Current Deferred Revenue	- 0.59	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.57	Retained Earnings